Pharmalittle: We’re reading about FDA plans for CAR-T therapies, skinny drug labels, and much more
In a closely watched case, the U.S. solicitor general urged the Supreme Court to review a controversy over so-called skinny ...
NTD: Rachel Pope, associate professor of urology, discussed the FDA's recent move to remove warnings from hormone replacement therapy packaging. “Hopefully, it will reduce the fear of women using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback